Mathew Blackman
Stock Analyst at Stifel
(4.71)
# 198
Out of 4,479 analysts
28
Total ratings
68%
Success rate
24.81%
Average return
Main Sectors:
Top Industries:
9 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Buy | $45 → $55 | $39.15 | +40.49% | 3 | May 22, 2024 | |
| INGN Inogen | Maintains: Hold | $6 → $7 | $7.67 | -8.74% | 5 | May 8, 2024 | |
| GMED Globus Medical | Maintains: Buy | $64 → $70 | $68.05 | +2.87% | 4 | May 8, 2024 | |
| CLPT ClearPoint Neuro | Reiterates: Buy | $8 → $9 | $5.30 | +69.81% | 2 | Mar 13, 2024 | |
| PODD Insulet | Maintains: Hold | $163 → $208 | $197.19 | +5.48% | 2 | Feb 5, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $25 → $24 | $9.90 | +142.42% | 3 | Nov 7, 2023 | |
| DXCM DexCom | Maintains: Buy | $155 → $145 | $112.49 | +28.90% | 4 | Oct 10, 2023 | |
| OFIX Orthofix Medical | Downgrades: Hold | $30 → $16 | $13.29 | +20.39% | 3 | Sep 12, 2023 | |
| AHCO AdaptHealth | Downgrades: Hold | $18 → $11 | $9.89 | +11.22% | 2 | May 10, 2023 |
Tandem Diabetes Care
May 22, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $39.15
Upside: +40.49%
Inogen
May 8, 2024
Maintains: Hold
Price Target: $6 → $7
Current: $7.67
Upside: -8.74%
Globus Medical
May 8, 2024
Maintains: Buy
Price Target: $64 → $70
Current: $68.05
Upside: +2.87%
ClearPoint Neuro
Mar 13, 2024
Reiterates: Buy
Price Target: $8 → $9
Current: $5.30
Upside: +69.81%
Insulet
Feb 5, 2024
Maintains: Hold
Price Target: $163 → $208
Current: $197.19
Upside: +5.48%
Alphatec Holdings
Nov 7, 2023
Maintains: Buy
Price Target: $25 → $24
Current: $9.90
Upside: +142.42%
DexCom
Oct 10, 2023
Maintains: Buy
Price Target: $155 → $145
Current: $112.49
Upside: +28.90%
Orthofix Medical
Sep 12, 2023
Downgrades: Hold
Price Target: $30 → $16
Current: $13.29
Upside: +20.39%
AdaptHealth
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $9.89
Upside: +11.22%